Table 4: The laboratory data of the patients in both naltrexone and placebo groups.

Total NLTX PlaceboP
Mean ± SDMedian (range)Mean ± SDMedian (range)Mean ± SDMedian (range)

WBC ×106 µL 11.0 (34 to 21.7) 10.1 (34 to 17) 11.4 (65 to 2.17)0.12
RBC ×106 µL 4.56 (3.87 to 5.9) 4.62 (3.87 to 5.52) 4.51 (3.91 to 5.9)0.40
Hb (mg/dL) 13.4 (1.3 to 16.6) 14.1 (9.1 to 16.2) 12.4 (1.3 to 16.6)0.10
Hct (%) 39 (30.1 to 49.8) 40.3 (30.1 to 48.4) 39 (34 to 49.8)0.64
Platelet ×103 µL 225 (46 to 599) 232 (97 to 599) 220 (46 to 396)0.53
Blood sugar (mg/dL) 106 (50 to 317) 91 (53 to 197) 118 (50 to 317)0.03
Blood urea (mg/dL) 24 (15 to 69) 24 (15 to 47) 26 (15 to 69)0.35
Creatinine (mg/dL) 0.9 (0.6 to 3) 0.9 (0.6 to 1.5) 0.9 (0.6 to 3)0.13
SGOT (U/L) 22 (11 to 241) 18 (12 to 63) 25 (11 to 241)0.04
SGPT (U/L) 18 (5 to 167) 16 (10 to 105) 21 (5 to 167)0.58
LDH (U/L) 422 (216 to 2780) 416 (290 to 2780) 422 (216 to 1324)0.26
CPK (U/L) 110 (50 to 4450) 99 (59 to 170) 144 (50 to 4450)0.04
ALP (U/L) 175 (11 to 320) 178 (98 to 310) 172 (11 to 320)0.80
Na (mEq/L) 139 (132 to 1346) 139 (132 to 1346) 140 (136 to 147)0.73
K (mEq/L) 4 (3.4 to 4.8) 4 (3.4 to 4.6) 4.1 (3.4 to 4.8)0.17
Bili. T (mg/dL) 0.5 (0 to 1.4) 0.5 (0 to 1.4) 0.5 (0 to 1.4)0.62
Bili. D (mg/dL) 0.2 (0.1 to 1) 0.2 (0.1 to 1) 0.1 (0.1 to 0.3)0.02

Based on Student’s t-test. Based on Mann-Whitney U test.